President Trump tells the story of his overweight friend who was able to buy a drug for weight loss for cheap in London, while prices in the US for the same drug costs north of $ 1,000.
Novo Nordisk said on Monday that it offers its diabetes medicine Ozempic for $ 499 per month for eligible cash payment type 2 diabetes patients in the US.
The company said in March that it reduced the price of its drugwegovy to $ 499. The two medicines are comparable, with Wegovy mainly prescribed for weight loss for obese patients. Ozempic is prescribed to patients with type 2 diabetes.
Eer Lilly announced earlier this year that it would expand the offer and reduce the costs of his weight loss medicine Zepbound again, again, effectively broadening access to more patients without insurance with his own self -paid pharmacy.
Novo Nordisk said on Monday that it offers its diabetes drug Ozempic for $ 499 per month to eligible customers in the US (Photo by Joel Saget / AFP via Getty Images / Getty Images)
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| NVO | Novo Nordisk a/s | 54.07 | +2.07 |
+3.98% |
Novo Nordisk lowers Wegovy prices in two for customers who pay money
The company, which has also seen a considerable profit Zepbound and Mounjaro -In the same medicine with different applications approved by the FDA, it was that the new bottles and prices are exclusively available via Lillydirect Self Pay Pharmacy Solutions.
Novo Nordisk Rival Eli Lilly makes competing drugs Zepbound and Mounjaro.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| Ly | Eli Lilly & Co. | 701.23 | +18.30 |
+2.68% |
Eli Lilly’s Zepbound reduces type 2 diabetes risk, research shows
The Novo offer is rolled out on several platforms. Ozempic will be available via the Novocare Pharmacy program – launched earlier this year to sell Wegovy outside the insurance – for the first time, said Novo.
It also said that it cooperates with TeleHealth Service Goodrx to offer both Wegovy and Ozempic for $ 499 a month.
The stock price of Goodrx rose nearly 30% after the announcement.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| GDRX | Goodrx Holdings Inc. | 5.22 | +1.49 |
+39.97% |
Get Fox Business on the Go by clicking here
President Donald Trump signed an executive order with the intention of making drug prices the same in the US as sold in other countries.
“He called me and he said,” Hey, strange happened. I just bought a medicine, the same company, the same plant, the same, everything, everything was the same. In one case I paid $ 1,300 in New York and in London I pay $ 88, “” “Trump told.” He said, “What’s going on?”
The president has said that lower drug prices in the US is a priority for administration.
